Irena Melnikova, Ph.D., is a Managing Director in Investment Banking at SVB Leerink covering the Biopharma sector. Dr. Melnikova advises clients on equity financing strategies, including private placement financings, initial public offerings, alternative go-public strategies and follow-ons.
Dr. Melnikova was previously a Director of Investment Banking at the firm in 2005. A few years later she took the role as Principal at TVM Capital, a global life sciences venture capital firm, investing in biopharmaceutical and medical technology companies. Before rejoining SVB Leerink in 2014, Dr. Melnikova was a Managing Director at Burrill & Company, and prior to that, Director of Strategy and External Innovation at Sanofi responsible for identifying partnering opportunities in the Northeast U.S.
Dr. Melnikova earned an M.S. with Honors in Chemical Engineering from Russian University of Chemical Technology and a Ph.D. in Molecular Medicine/Molecular Biology from the University of Texas.